HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-MAY-14 4PNI TITLE BOVINE G PROTEIN-COUPLED RECEPTOR KINASE 1 IN COMPLEX WITH GSK2163632A COMPND MOL_ID: 1; COMPND 2 MOLECULE: RHODOPSIN KINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: RK,G PROTEIN-COUPLED RECEPTOR KINASE 1; COMPND 5 EC: 2.7.11.14; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 GENE: GRK1, RHOK; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS AGC FAMILY KINASE, SER/THR KINASE, RGS HOMOLOGY DOMAIN, G PROTEIN KEYWDS 2 COUPLED RECEPTOR KINASE, GRK, GRK1, RHODOPSIN KINASE, HYDROLYASE, KEYWDS 3 GPCR, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.T.HOMAN,J.J.G.TESMER REVDAT 5 27-DEC-23 4PNI 1 REMARK REVDAT 4 04-DEC-19 4PNI 1 REMARK REVDAT 3 06-SEP-17 4PNI 1 SOURCE REMARK REVDAT 2 28-JAN-15 4PNI 1 JRNL REVDAT 1 08-OCT-14 4PNI 0 JRNL AUTH K.T.HOMAN,K.M.LARIMORE,J.M.ELKINS,M.SZKLARZ,S.KNAPP, JRNL AUTH 2 J.J.TESMER JRNL TITL IDENTIFICATION AND STRUCTURE-FUNCTION ANALYSIS OF SUBFAMILY JRNL TITL 2 SELECTIVE G PROTEIN-COUPLED RECEPTOR KINASE INHIBITORS. JRNL REF ACS CHEM.BIOL. V. 10 310 2015 JRNL REFN ESSN 1554-8937 JRNL PMID 25238254 JRNL DOI 10.1021/CB5006323 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 51503 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2753 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3672 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.20 REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE SET COUNT : 208 REMARK 3 BIN FREE R VALUE : 0.3530 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3956 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 218 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.25000 REMARK 3 B22 (A**2) : 0.22000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.125 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.125 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.097 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.259 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.972 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.957 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4126 ; 0.020 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3927 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5578 ; 2.004 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9032 ; 0.971 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 498 ; 6.202 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 203 ;36.898 ;23.596 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 714 ;15.169 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 33 ;19.823 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 579 ; 0.129 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4692 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 995 ; 0.006 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1989 ; 4.252 ; 4.560 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1990 ; 4.250 ; 4.560 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2488 ; 5.344 ; 6.811 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2488 ; 5.344 ; 6.811 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2137 ; 5.296 ; 5.060 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2138 ; 5.295 ; 5.060 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3091 ; 7.700 ; 7.375 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4763 ; 9.239 ;36.559 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4691 ; 9.248 ;36.385 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4PNI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAY-14. REMARK 100 THE DEPOSITION ID IS D_1000201753. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9787 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51503 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 10.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10300 REMARK 200 FOR THE DATA SET : 90.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 19.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MES, PEG 3350, NACL, PH 6.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.28300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 102.74950 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.28300 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 102.74950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -129.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 66.56600 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 PHE A 3 REMARK 465 GLY A 4 REMARK 465 SER A 5 REMARK 465 LEU A 6 REMARK 465 GLU A 7 REMARK 465 THR A 8 REMARK 465 VAL A 9 REMARK 465 VAL A 10 REMARK 465 ALA A 11 REMARK 465 ASN A 12 REMARK 465 SER A 13 REMARK 465 ALA A 14 REMARK 465 PHE A 15 REMARK 465 ILE A 16 REMARK 465 ALA A 17 REMARK 465 ALA A 18 REMARK 465 ARG A 19 REMARK 465 GLY A 20 REMARK 465 SER A 21 REMARK 465 PHE A 22 REMARK 465 ASP A 23 REMARK 465 ALA A 24 REMARK 465 SER A 25 REMARK 465 SER A 26 REMARK 465 GLY A 27 REMARK 465 PRO A 28 REMARK 465 ALA A 29 REMARK 465 GLN A 482 REMARK 465 ASP A 483 REMARK 465 VAL A 484 REMARK 465 GLY A 485 REMARK 465 ALA A 486 REMARK 465 PHE A 487 REMARK 465 SER A 488 REMARK 465 THR A 489 REMARK 465 VAL A 490 REMARK 465 LYS A 491 REMARK 465 GLY A 492 REMARK 465 VAL A 493 REMARK 465 ASP A 534 REMARK 465 GLY A 535 REMARK 465 GLN A 536 REMARK 465 MET A 537 REMARK 465 PRO A 538 REMARK 465 ASP A 539 REMARK 465 ASP A 540 REMARK 465 MET A 541 REMARK 465 LYS A 542 REMARK 465 GLY A 543 REMARK 465 VAL A 544 REMARK 465 SER A 545 REMARK 465 GLY A 546 REMARK 465 GLN A 547 REMARK 465 GLU A 548 REMARK 465 ALA A 549 REMARK 465 ALA A 550 REMARK 465 PRO A 551 REMARK 465 SER A 552 REMARK 465 SER A 553 REMARK 465 LYS A 554 REMARK 465 SER A 555 REMARK 465 GLY A 556 REMARK 465 MET A 557 REMARK 465 CYS A 558 REMARK 465 VAL A 559 REMARK 465 LEU A 560 REMARK 465 SER A 561 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 722 O HOH A 722 2565 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 245 NE - CZ - NH1 ANGL. DEV. = 4.8 DEGREES REMARK 500 MET A 264 CG - SD - CE ANGL. DEV. = -16.1 DEGREES REMARK 500 TYR A 312 CB - CG - CD1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ASP A 314 CB - CG - OD1 ANGL. DEV. = 5.4 DEGREES REMARK 500 ARG A 329 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 329 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 VAL A 337 CB - CA - C ANGL. DEV. = -14.4 DEGREES REMARK 500 ARG A 390 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG A 404 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG A 447 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 474 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 138 -25.35 -151.59 REMARK 500 PHE A 143 -3.00 87.36 REMARK 500 GLN A 156 -112.65 -99.58 REMARK 500 ASP A 314 39.38 -142.85 REMARK 500 ASP A 332 73.26 54.91 REMARK 500 ASP A 332 73.26 55.62 REMARK 500 ASP A 367 -154.87 -132.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KQQ A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 607 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4L9I RELATED DB: PDB REMARK 900 4L9I CONTAINS THE SAME PROTEIN WITH PAROXETINE BOUND REMARK 900 RELATED ID: 4PNK RELATED DB: PDB DBREF 4PNI A 1 561 UNP P28327 RK_BOVIN 1 561 SEQRES 1 A 561 MET ASP PHE GLY SER LEU GLU THR VAL VAL ALA ASN SER SEQRES 2 A 561 ALA PHE ILE ALA ALA ARG GLY SER PHE ASP ALA SER SER SEQRES 3 A 561 GLY PRO ALA SER ARG ASP ARG LYS TYR LEU ALA ARG LEU SEQRES 4 A 561 LYS LEU PRO PRO LEU SER LYS CYS GLU ALA LEU ARG GLU SEQRES 5 A 561 SER LEU ASP LEU GLY PHE GLU GLY MET CYS LEU GLU GLN SEQRES 6 A 561 PRO ILE GLY LYS ARG LEU PHE GLN GLN PHE LEU ARG THR SEQRES 7 A 561 HIS GLU GLN HIS GLY PRO ALA LEU GLN LEU TRP LYS ASP SEQRES 8 A 561 ILE GLU ASP TYR ASP THR ALA ASP ASP ALA LEU ARG PRO SEQRES 9 A 561 GLN LYS ALA GLN ALA LEU ARG ALA ALA TYR LEU GLU PRO SEQRES 10 A 561 GLN ALA GLN LEU PHE CYS SER PHE LEU ASP ALA GLU THR SEQRES 11 A 561 VAL ALA ARG ALA ARG ALA GLY ALA GLY ASP GLY LEU PHE SEQRES 12 A 561 GLN PRO LEU LEU ARG ALA VAL LEU ALA HIS LEU GLY GLN SEQRES 13 A 561 ALA PRO PHE GLN GLU PHE LEU ASP SER LEU TYR PHE LEU SEQRES 14 A 561 ARG PHE LEU GLN TRP LYS TRP LEU GLU ALA GLN PRO MET SEQRES 15 A 561 GLY GLU ASP TRP PHE LEU ASP PHE ARG VAL LEU GLY ARG SEQRES 16 A 561 GLY GLY PHE GLY GLU VAL PHE ALA CYS GLN MET LYS ALA SEQRES 17 A 561 THR GLY LYS LEU TYR ALA CYS LYS LYS LEU ASN LYS LYS SEQRES 18 A 561 ARG LEU LYS LYS ARG LYS GLY TYR GLN GLY ALA MET VAL SEQRES 19 A 561 GLU LYS LYS ILE LEU ALA LYS VAL HIS SER ARG PHE ILE SEQRES 20 A 561 VAL SER LEU ALA TYR ALA PHE GLU THR LYS THR ASP LEU SEQRES 21 A 561 CYS LEU VAL MET THR ILE MET ASN GLY GLY ASP ILE ARG SEQRES 22 A 561 TYR HIS ILE TYR ASN VAL ASP GLU ASP ASN PRO GLY PHE SEQRES 23 A 561 GLN GLU PRO ARG ALA ILE PHE TYR THR ALA GLN ILE VAL SEQRES 24 A 561 SER GLY LEU GLU HIS LEU HIS GLN ARG ASN ILE ILE TYR SEQRES 25 A 561 ARG ASP LEU LYS PRO GLU ASN VAL LEU LEU ASP ASP ASP SEQRES 26 A 561 GLY ASN VAL ARG ILE SER ASP LEU GLY LEU ALA VAL GLU SEQRES 27 A 561 LEU LYS ALA GLY GLN THR LYS THR LYS GLY TYR ALA GLY SEQRES 28 A 561 THR PRO GLY PHE MET ALA PRO GLU LEU LEU LEU GLY GLU SEQRES 29 A 561 GLU TYR ASP PHE SER VAL ASP TYR PHE ALA LEU GLY VAL SEQRES 30 A 561 THR LEU TYR GLU MET ILE ALA ALA ARG GLY PRO PHE ARG SEQRES 31 A 561 ALA ARG GLY GLU LYS VAL GLU ASN LYS GLU LEU LYS GLN SEQRES 32 A 561 ARG VAL LEU GLU GLN ALA VAL THR TYR PRO ASP LYS PHE SEQRES 33 A 561 SER PRO ALA SER LYS ASP PHE CYS GLU ALA LEU LEU GLN SEQRES 34 A 561 LYS ASP PRO GLU LYS ARG LEU GLY PHE ARG ASP GLY SER SEQRES 35 A 561 CYS ASP GLY LEU ARG THR HIS PRO LEU PHE ARG ASP ILE SEQRES 36 A 561 SER TRP ARG GLN LEU GLU ALA GLY MET LEU THR PRO PRO SEQRES 37 A 561 PHE VAL PRO ASP SER ARG THR VAL TYR ALA LYS ASN ILE SEQRES 38 A 561 GLN ASP VAL GLY ALA PHE SER THR VAL LYS GLY VAL ALA SEQRES 39 A 561 PHE GLU LYS ALA ASP THR GLU PHE PHE GLN GLU PHE ALA SEQRES 40 A 561 SER GLY THR CYS PRO ILE PRO TRP GLN GLU GLU MET ILE SEQRES 41 A 561 GLU THR GLY VAL PHE GLY ASP LEU ASN VAL TRP ARG PRO SEQRES 42 A 561 ASP GLY GLN MET PRO ASP ASP MET LYS GLY VAL SER GLY SEQRES 43 A 561 GLN GLU ALA ALA PRO SER SER LYS SER GLY MET CYS VAL SEQRES 44 A 561 LEU SER HET KQQ A 601 39 HET CL A 602 1 HET CL A 603 1 HET CL A 604 1 HET CL A 605 1 HET CL A 606 1 HET CL A 607 1 HETNAM KQQ 3-[(2-{[1-(N,N-DIMETHYLGLYCYL)-6-METHOXY-4,4-DIMETHYL- HETNAM 2 KQQ 1,2,3,4-TETRAHYDROQUINOLIN-7-YL]AMINO}-7H-PYRROLO[2,3- HETNAM 3 KQQ D]PYRIMIDIN-4-YL)AMINO]THIOPHENE-2-CARBOXAMIDE HETNAM CL CHLORIDE ION FORMUL 2 KQQ C27 H32 N8 O3 S FORMUL 3 CL 6(CL 1-) FORMUL 9 HOH *218(H2 O) HELIX 1 AA1 ASP A 32 ALA A 37 1 6 HELIX 2 AA2 PRO A 43 LYS A 46 5 4 HELIX 3 AA3 CYS A 47 LEU A 54 1 8 HELIX 4 AA4 GLY A 57 LEU A 63 1 7 HELIX 5 AA5 GLN A 65 THR A 78 1 14 HELIX 6 AA6 HIS A 79 GLN A 81 5 3 HELIX 7 AA7 HIS A 82 THR A 97 1 16 HELIX 8 AA8 ASP A 99 ALA A 101 5 3 HELIX 9 AA9 LEU A 102 LEU A 115 1 14 HELIX 10 AB1 ASP A 127 ALA A 136 1 10 HELIX 11 AB2 PHE A 143 GLY A 155 1 13 HELIX 12 AB3 GLN A 156 ASP A 164 1 9 HELIX 13 AB4 SER A 165 ALA A 179 1 15 HELIX 14 AB5 GLY A 183 ASP A 185 5 3 HELIX 15 AB6 LYS A 220 ARG A 226 1 7 HELIX 16 AB7 GLY A 228 VAL A 242 1 15 HELIX 17 AB8 ILE A 272 ASN A 278 1 7 HELIX 18 AB9 GLN A 287 GLN A 307 1 21 HELIX 19 AC1 LYS A 316 GLU A 318 5 3 HELIX 20 AC2 ASP A 332 ALA A 336 5 5 HELIX 21 AC3 ALA A 357 LEU A 362 1 6 HELIX 22 AC4 PHE A 368 ALA A 385 1 18 HELIX 23 AC5 GLU A 397 GLN A 408 1 12 HELIX 24 AC6 SER A 417 GLN A 429 1 13 HELIX 25 AC7 ASP A 431 ARG A 435 5 5 HELIX 26 AC8 CYS A 443 THR A 448 1 6 HELIX 27 AC9 HIS A 449 ARG A 453 5 5 HELIX 28 AD1 SER A 456 ALA A 462 1 7 HELIX 29 AD2 ARG A 474 ALA A 478 5 5 HELIX 30 AD3 GLU A 496 ALA A 507 1 12 HELIX 31 AD4 CYS A 511 THR A 522 1 12 HELIX 32 AD5 GLY A 523 ASN A 529 1 7 SHEET 1 AA1 6 PHE A 187 GLY A 196 0 SHEET 2 AA1 6 GLY A 199 MET A 206 -1 O VAL A 201 N GLY A 194 SHEET 3 AA1 6 LEU A 212 ASN A 219 -1 O LYS A 217 N GLU A 200 SHEET 4 AA1 6 ASP A 259 THR A 265 -1 O MET A 264 N ALA A 214 SHEET 5 AA1 6 LEU A 250 GLU A 255 -1 N TYR A 252 O VAL A 263 SHEET 6 AA1 6 GLY A 509 THR A 510 -1 O GLY A 509 N ALA A 253 SHEET 1 AA2 3 GLY A 270 ASP A 271 0 SHEET 2 AA2 3 VAL A 320 LEU A 322 -1 O LEU A 322 N GLY A 270 SHEET 3 AA2 3 VAL A 328 ILE A 330 -1 O ARG A 329 N LEU A 321 SHEET 1 AA3 2 ILE A 310 ILE A 311 0 SHEET 2 AA3 2 VAL A 337 GLU A 338 -1 O VAL A 337 N ILE A 311 SITE 1 AC1 11 LEU A 193 PHE A 198 ALA A 214 THR A 265 SITE 2 AC1 11 MET A 267 ASN A 268 GLY A 270 ASP A 271 SITE 3 AC1 11 LEU A 321 ARG A 474 THR A 475 SITE 1 AC2 3 LEU A 166 ARG A 170 GLN A 173 SITE 1 AC3 2 GLN A 287 ARG A 290 SITE 1 AC4 4 ARG A 386 PHE A 389 GLN A 408 ARG A 453 SITE 1 AC5 2 TRP A 457 ARG A 458 SITE 1 AC6 5 GLY A 387 PRO A 388 PHE A 389 ARG A 390 SITE 2 AC6 5 HOH A 846 SITE 1 AC7 1 LYS A 90 CRYST1 45.485 66.566 205.499 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021985 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015023 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004866 0.00000